XML 41 R30.htm IDEA: XBRL DOCUMENT v3.19.1
Stock award plan (Tables)
3 Months Ended
Mar. 31, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Summary of stock option activity
A summary of stock option activity is as follows:
 
 
Number of
options
 
Weighted-
average
exercise
price
 
Weighted-
average
remaining
contractual
term
 
Aggregate
intrinsic
value
 
 
 
 
 
 
 
 
(in
thousands)
Outstanding at December 31, 2018
 
8,534,358

 
$
28.58

 
 
 
 

Granted
 
2,490,970

 
$
33.01

 
 
 
 

Exercised
 
(80,826
)
 
$
15.85

 
 
 
 

Forfeited/Cancelled
 
(133,119
)
 
$
29.10

 
 
 
 

Outstanding at March 31, 2019
 
10,811,383

 
$
29.67

 
7.72 years
 
$
117,201

Vested or Expected to vest at March 31, 2019
 
5,364,300

 
$
28.40

 
9.15 years
 
$
53,343

Exercisable at March 31, 2019
 
4,987,460

 
$
31.00

 
6.04 years
 
$
60,063

Schedule of assumptions used to estimate fair values of grants made on the date of grant
The fair value of grants made in the three months ended March 31, 2019 was contemporaneously estimated on the date of grant using the following assumptions:
 
 
Three months ended
March 31, 2019
Risk-free interest rate
 
2.53 - 2.63%
Expected volatility
 
62.62 - 63.01%
Expected term
 
6.11 years
Summary of information on the Company's restricted stock
The following table summarizes information on the Company’s restricted stock awards and units:
 
 
Restricted Stock Awards and Units
 
 
Number of
Shares
 
Weighted
Average
Grant
Date Fair
Value
January 1, 2019
 
571,479

 
$
17.61

Granted
 
304,549

 
$
32.94

Vested
 
(161,077
)
 
$
17.60

Forfeited
 
(19,612
)
 
$
20.42

Unvested at March 31, 2019
 
695,339

 
$
24.27

Schedule of share-based compensation expense recorded in the statement of operations
The Company recorded share-based compensation expense in the statement of operations related to incentive stock options, nonstatutory stock options, restricted stock awards, restricted stock units and the ESPP as follows:
 
 
Three Months Ended March 31,
 
 
2019
 
2018
Research and development
 
$
4,686

 
$
3,747

Selling, general and administrative
 
4,577

 
4,001

Total
 
$
9,263

 
$
7,748